MYCIO Wealth Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,779
Closed -$645K 416
2019
Q4
$645K Buy
6,779
+4,220
+165% +$365K 0.04% 169
2019
Q3
$195K Hold
2,559
0.01% 297
2019
Q2
$224K Sell
2,559
-100
-4% -$8.53K 0.02% 283
2019
Q1
$241K Buy
+2,659
New +$226K 0.02% 253
2018
Q4
Sell
-2,678
Closed -$257K 310
2018
Q3
$257K Buy
2,678
+62
+2% +$6.01K 0.02% 237
2018
Q2
$249K Buy
+2,616
New +$240K 0.03% 237
2016
Q4
Sell
-85
Closed -$6K 679
2016
Q3
$6K Hold
85
﹤0.01% 647
2016
Q2
$5K Buy
85
+1
+1% +$55 ﹤0.01% 675
2016
Q1
$4K Hold
84
﹤0.01% 640
2015
Q4
$6K Hold
84
﹤0.01% 594
2015
Q3
$5K Hold
84
﹤0.01% 669
2015
Q2
$7K Hold
84
﹤0.01% 565
2015
Q1
$6K Hold
84
﹤0.01% 538
2014
Q4
$5K Buy
+84
New +$4.79K ﹤0.01% 522

Other funds holding XBI

MYCIO Wealth Partners's XBI Position: Q1 2020 in Review

MYCIO Wealth Partners sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2020, closing a stake of 6,779 shares — an estimated $645K sold.

MYCIO Wealth Partners first reported a position in XBI in Q4 2014 and held it in 14 quarters. The position peaked at $645K in Q4 2019. 458 funds tracked by Wall St. Rank hold XBI as of Q1 2020.

  • MYCIO Wealth Partners reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2020 after selling out during the quarter.
  • MYCIO Wealth Partners sold 6,779 State Street SPDR S&P Biotech ETF shares in Q1 2020, an estimated $645K.
  • MYCIO Wealth Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and held it in 14 quarters.
  • MYCIO Wealth Partners's State Street SPDR S&P Biotech ETF position peaked at $645K in Q4 2019.
  • 458 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2020.

Based on MYCIO Wealth Partners's 13F filing for Q1 2020, filed 14 May 2020.